Skip to main content
Screener/Healthcare/Biotechnology

SABS — SAB Biotherapeutics, Inc.

NASDAQ
$4.24+0.15 (+3.67%)
Penny StockUnder $5Healthcare
$1.60
$6.60
$3.79
$4.59
EPS (TTM)$-2.67
P/E Ratio5.14
Dividend Yield—
Market Cap$33.2M
Volume4.73M
Prev Close$4.09
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$16.9M$-0.81——
Q3 '25$0$45.4M$-0.21——
Q2 '25$0-$10.1M$-1.09——
Q1 '25$0-$5.2M$-0.56——
Q4 '24$115K-$11.4M$-1.23-585.0%-9934.5%
Q3 '24$0-$10.3M$-1.12——
Q2 '24$263K-$7.3M$-0.79-288.4%-2787.7%
Q1 '24$945K-$5.0M$-0.54-110.1%-532.1%
Get Your Daily Market Recap